Watch Ticker

BiomX Inc.

Go to BiomX Inc. Website

$0.00

(%)

Live

Previous Close

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$18.8 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

NYSE American, LLC

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harm...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

BiomX - BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Abstract selected as a “Top Poster”, ranking it among the 1-2% of top-rated abstracts in the category submitted and accepted at ECCMID 2024 Abstract selected as a “Top Poster”, ranking it among the 1-2% of top-rated abstracts in the category submitted and accepted at ECCMID 2024

Related tickers: PHGE.

Read Full Article

BiomX - BiomX Announces the Appointment of Susan Blum to its Board of Directors

CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the appointment of Susan Blum to its Board of Directors. Ms. Blum was also appointed to serve as a member and chair of the audit committee of the Board.

Related tickers: PHGE.

Read Full Article

Trending Tickers

DATS

XNAS

$1.28

(%)

LASE

XNAS

$2.07

(%)

NYCB

XNYS

$3.06

(%)

PACW

XNAS

$7.54

(%)

MLGO

XNAS

$0.00

(%)